A look at the weighted underlying holdings of the First Trust Nasdaq Pharmaceuticals ETF (Symbol: FTXH) shows an impressive 14.9% of holdings on a weighted basis have experienced insider buying within the past six months.
Medicines Co (Symbol: MDCO), which makes up 2.20% of the First Trust Nasdaq Pharmaceuticals ETF (Symbol: FTXH), has seen 2 directors and officers purchase shares in the past six months, according to the recent Form 4 data. The ETF holds a total of $41,093 worth of MDCO, making it the #16 largest holding. The table below details the recent insider buying activity observed at MDCO:
MDCO - last trade: $34.81 - Recent Insider Buys:
|12/08/2016||Fredric N. Eshelman||Director||621,720||$33.77||$20,993,462|
|12/08/2016||Christopher T. Cox||EVP & Chief Corp. Dev. Officer||105,500||$33.20||$3,502,950|